The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...

In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.

Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...

When I look back on my journey, I’m reminded of how much can change when you are able to ask for, and receive, help. My name is Dr. Christopher Schenewerk. I am a physician, a father, and a ...

While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same ...

A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...

Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions.

With the administration change in Washington, questions abound regarding the impact of new healthcare appointees across healthcare agencies. While it will take time to enact any presumed or ...

Hone Health, a telehealth clinic for preventive longevity care, announced Tuesday that it has raised $33 million in Series A funding, which it is using to acquire home health company ivee.

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...

Insurers of qualified health plans on HealthCare.gov denied about one in five in-network claims and 37% of out-of-network claims in 2023, according to a new analysis from KFF. KFF is a nonprofit ...